ChromaDex (CDXC)
(Delayed Data from NSDQ)
$2.67 USD
+0.23 (9.43%)
Updated Jun 26, 2024 04:00 PM ET
After-Market: $2.67 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Brokerage Reports
ChromaDex Corporation [CDXC]
Reports for Purchase
Showing records 101 - 115 ( 115 total )
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Preliminary Fourth Quarter 2016 Revenue Guidance Released; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Longmont R-D Center Opens; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Longmont R-D Center Opens; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and a 12-month price target of $6.00.
Provider: H.C. Wainwright & Co., Inc.
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and a 12-month price target of $6.00.
Provider: Rodman & Renshaw, Co.
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
We are terminating research coverage due to the termination or loss of the primary and/or secondary analysts responsible for coverage.
Provider: DAWSON JAMES SECURITIES, INC.
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Chromadex provides products and services to the natural foods industry
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
BluScienceTM Products in Walgreens, GNCBluScienceTM Initial Advertising Campaign Launched
Provider: REDCHIP
Analyst: PFISTER T
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Announced Common Stock Sale Consummated New Investment Acquired from OPKO Health, Inc
Provider: REDCHIP
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Initiating coverage with a 12-month price target of $2.20 and rating of STRONG BUY.
Provider: REDCHIP
Analyst: RESNIK P
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
New distribution & development partners pave the way for growth in 2011
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
INITIATION REPORT
Provider: DAWSON JAMES SECURITIES, INC.